These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 27409410)
1. Prostaglandin D2 receptor antagonists in early development as potential therapeutic options for asthma. Santus P; Radovanovic D Expert Opin Investig Drugs; 2016 Sep; 25(9):1083-92. PubMed ID: 27409410 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of antagonists for chemoattractant receptor-homologous molecule expressed on Th2 cells in adult patients with asthma: a meta-analysis and systematic review. Yang J; Luo J; Yang L; Yang D; Wang D; Liu B; Huang T; Wang X; Liang B; Liu C Respir Res; 2018 Nov; 19(1):217. PubMed ID: 30413187 [TBL] [Abstract][Full Text] [Related]
4. Investigational prostaglandin D2 receptor antagonists for airway inflammation. Santini G; Mores N; Malerba M; Mondino C; Macis G; Montuschi P Expert Opin Investig Drugs; 2016 Jun; 25(6):639-52. PubMed ID: 27094922 [TBL] [Abstract][Full Text] [Related]
5. Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonists in asthma: a systematic review and meta-analysis protocol. Liu W; Min J; Jiang H; Mao B BMJ Open; 2018 Apr; 8(4):e020882. PubMed ID: 29678990 [TBL] [Abstract][Full Text] [Related]
6. The prostaglandin D Domingo C; Palomares O; Sandham DA; Erpenbeck VJ; Altman P Respir Res; 2018 Sep; 19(1):189. PubMed ID: 30268119 [TBL] [Abstract][Full Text] [Related]
7. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571 [TBL] [Abstract][Full Text] [Related]
8. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation. Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802 [TBL] [Abstract][Full Text] [Related]
9. Same Target, Different Therapeutic Outcomes: The Case of CAY10471 and Fevipiprant on CRTh2 Receptor in Treatment of Allergic Rhinitis and Asthma. Issahaku AR; Agoni C; Soremekun OS; Kubi PA; Kumi RO; Olotu FA; Soliman MES Comb Chem High Throughput Screen; 2019; 22(8):521-533. PubMed ID: 31538888 [TBL] [Abstract][Full Text] [Related]
10. Antagonists of the prostaglandin D2 receptor CRTH2. Pettipher R; Hansel TT Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of "chemoattractant receptor homologous molecule expressed on Th2 cells" (CRTH2). Tasaki M; Kobayashi M; Tenda Y; Tsujimoto S; Nakazato S; Numazaki M; Hirano Y; Matsuda H; Terasaka T; Miyao Y; Shimizu Y; Hirayama Y Eur J Pharm Sci; 2013 Jun; 49(3):434-40. PubMed ID: 23624353 [TBL] [Abstract][Full Text] [Related]
12. Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis. Pettipher R; Whittaker M J Med Chem; 2012 Apr; 55(7):2915-31. PubMed ID: 22224640 [No Abstract] [Full Text] [Related]
13. A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep. Shichijo M; Arimura A; Hirano Y; Yasui K; Suzuki N; Deguchi M; Abraham WM Clin Exp Allergy; 2009 Sep; 39(9):1404-14. PubMed ID: 19486034 [TBL] [Abstract][Full Text] [Related]
14. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases. Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandin D₂ receptor CRTH2 antagonists for the treatment of inflammatory diseases. Chen JJ; Budelsky AL Prog Med Chem; 2011; 50():49-107. PubMed ID: 21315928 [No Abstract] [Full Text] [Related]
16. DP(2) receptor antagonists in development. Norman P Expert Opin Investig Drugs; 2010 Aug; 19(8):947-61. PubMed ID: 20615077 [TBL] [Abstract][Full Text] [Related]
17. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2. Armer RE; Ashton MR; Boyd EA; Brennan CJ; Brookfield FA; Gazi L; Gyles SL; Hay PA; Hunter MG; Middlemiss D; Whittaker M; Xue L; Pettipher R J Med Chem; 2005 Oct; 48(20):6174-7. PubMed ID: 16190744 [TBL] [Abstract][Full Text] [Related]
19. A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma. Miller D; Wood C; Bateman E; LaForce C; Blatchford J; Hilbert J; Gupta A; Fowler A Allergy Asthma Proc; 2017 Mar; 38(2):157-164. PubMed ID: 28234053 [TBL] [Abstract][Full Text] [Related]
20. Role of prostaglandin D2 /CRTH2 pathway on asthma exacerbation induced by Aspergillus fumigatus. Liu H; Zheng M; Qiao J; Dang Y; Zhang P; Jin X Immunology; 2014 May; 142(1):78-88. PubMed ID: 24329550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]